COMMUNIQUÉS West-GlobeNewswire

Skyline Medical Issues Letter to Shareholders
07/12/2017
MINNEAPOLIS, Dec. 07, 2017 (GLOBE NEWSWIRE) -- Skyline Medical Inc . (NASDAQ: SKLN ) (“Skyline” or the “Company”), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, [...]
Gilead Sciences to Acquire Cell Design Labs
07/12/2017
– Demonstrates Gilead’s Deep Commitment to Cell Therapy – – Novel Cell Engineering Technologies with the Potential to Drive Discovery and Development of New Anti-Cancer Medicines – – Structured Buy Out to Acquire Cell [...]
National Research Corporation Declares Quarterly Dividend
07/12/2017
Lincoln, Nebraska, Dec. 07, 2017 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ:NRCIA and NRCIB) today announced that its Board of Directors has declared a quarterly cash dividend of $0.10 (ten cents) per [...]
Flexion Therapeutics Enrolls First Patient in Phase 2 Pharmacokinetics and Safety Study of ZILRETTA™ (triamcinolone acetonide extended-release injectable suspension) in Bilateral Osteoarthritis of the Knee
07/12/2017
BURLINGTON, Mass., Dec. 07, 2017 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq: FLXN ) announced today the enrollment of the first patient in a clinical trial to evaluate the pharmacokinetics (PK) and safety of [...]
The Cooper Companies Announces Fourth Quarter and Full Year 2017 Results
07/12/2017
PLEASANTON, Calif., Dec. 07, 2017 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO ) today announced financial results for the fiscal fourth quarter and full year ended October 31, 2017. Fourth quarter revenue [...]
Intercept to Present at Upcoming Conference
07/12/2017
NEW YORK, Dec. 07, 2017 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT ), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non- [...]
Peregrine Pharmaceuticals Declares Quarterly Dividend on its Series E Convertible Preferred Stock
07/12/2017
TUSTIN, Calif., Dec. 07, 2017 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) (Nasdaq: PPHMP ) today announced that its Board of Directors has declared a quarterly cash dividend payment on the [...]
Optinose to Present at BMO Capital Markets Prescription for Success Healthcare Conference
07/12/2017
YARDLEY, Pa., Dec. 07, 2017 (GLOBE NEWSWIRE) -- Optinose (NASDAQ: OPTN ), a pharmaceutical company focused on patients treated by ENT and allergy specialists, today announced that Chief Executive Officer Peter Miller [...]
Aeglea BioTherapeutics to Present at BMO Capital Markets Prescriptions for Success Healthcare Conference
07/12/2017
AUSTIN, Texas, Dec. 07, 2017 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE ), a biotechnology company committed to the discovery and development of engineered human enzyme therapeutics for patients with [...]
Prolonged Progression-Free Survival Reinforces Tucatinib’s Potential for Patients with Advanced HER2+ Metastatic Breast Cancer
07/12/2017
SAN ANTONIO, Dec. 07, 2017 (GLOBE NEWSWIRE) -- Cascadian Therapeutics, Inc. (NASDAQ: CASC ), a clinical-stage biopharmaceutical company, today announced that tucatinib in combination with standard of care agents [...]
Fennec Announces Proposed Public Offering of Common Shares
07/12/2017
RESEARCH TRIANGLE PARK, N.C., Dec. 07, 2017 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC ) (TSX: FRX ), a biotechnology company focused on the development of PEDMARK™ (a unique formulation of sodium [...]
CTI Clinical Trial and Consulting Services Announces Acquisition of Eurotrials
07/12/2017
COVINGTON, Ky., Dec. 07, 2017 (GLOBE NEWSWIRE) -- CTI Clinical Trial and Consulting Services (CTI), a global, privately held, full-service contract research organization announces the acquisition of Eurotrials, a full- [...]
BioInformatics LLC Expands Analyst Team and Customer Outreach
07/12/2017
ARLINGTON, Va., Dec. 07, 2017 (GLOBE NEWSWIRE) -- BioInformatics LLC announced a significant expansion of its Strategic Directions International (SDi) division to enhance the range of market research products and [...]
Tempus Unveils Tempus O, a Platform to Structure and Annotate Clinical Data at Scale
07/12/2017
CHICAGO, Dec. 07, 2017 (GLOBE NEWSWIRE) -- Tempus, a technology company focused on helping doctors personalize cancer care by collecting and analyzing large volumes of molecular and clinical data today announced the [...]
Annual General Meeting in Coloplast A/S - Election of own Chairman and Deputy Chairman
07/12/2017
See enclosed pdf.
Articles of Association for Coloplast A/S
07/12/2017
See enclosed pdf.
Annual General Meeting of Coloplast A/S
07/12/2017
The Annual General Meeting of Coloplast A/S has just been adjourned. See the report on transactions in the enclosed pdf. The report is attached in Danish and English.
Crown Bioscience Releases Scientific Posters Detailing Innovations in Preclinical Cancer Pharmacology
07/12/2017
Presentation of Posters by Expert Scientists Now Available On-Demand on Crown Bioscience’s Website https://www.crownbio.com/eortc17-posters SANTA CLARA, Calif., Dec. 07, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience , a [...]
Hospitals Save Lives and Money by Investing in Climate Resilience
07/12/2017
BOSTON, Dec. 07, 2017 (GLOBE NEWSWIRE) -- In the wake of costly storms and wildfires in 2017, health care leaders can safeguard lives and their organization's financial viability by investing in climate resilience, [...]

Pages